Analysts See $0.52 EPS for LivaNova PLC (LIVN)

April 17, 2018 - By Mona Holcomb


Analysts expect LivaNova PLC (NASDAQ:LIVN) to report $0.52 EPS on May, 2.They anticipate $0.19 EPS change or 26.76 % from last quarter’s $0.71 EPS. LIVN’s profit would be $25.11M giving it 42.55 P/E if the $0.52 EPS is correct. After having $0.88 EPS previously, LivaNova PLC’s analysts see -40.91 % EPS growth. The stock increased 1.49% or $1.3 during the last trading session, reaching $88.5. About 62,292 shares traded. LivaNova PLC (NASDAQ:LIVN) has risen 66.28% since April 17, 2017 and is uptrending. It has outperformed by 54.73% the S&P500.

LivaNova PLC, a medical device company, designs, develops, makes, and sells therapeutic solutions worldwide. The company has market cap of $4.27 billion. It operates in three businesses: Neuromodulation, Cardiac Surgery, and Cardiac Rhythm Management. It currently has negative earnings. The Neuromodulation business designs, develops, and markets its Vagus Nerve Stimulation Therapy System, an implantable device to treat drug-resistant epilepsy and treatment-resistant depression (TRD).

LivaNova PLC (NASDAQ:LIVN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: